Krystal Biotech, Inc. KRYS Lessee Operating Lease Liability Undiscounted Excess Amount
Lessee Operating Lease Liability Undiscounted Excess Amount at other companies
Other financials
Where this comes from
Reported directly by Krystal Biotech, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount.
The official record: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Krystal Biotech, Inc.'s lessee operating lease liability undiscounted excess amount.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Krystal Biotech, Inc.'s lessee operating lease liability undiscounted excess amount?
- Krystal Biotech, Inc. (KRYS) reported lessee operating lease liability undiscounted excess amount of $7.46M in Q1 2026.
- How has Krystal Biotech, Inc.'s lessee operating lease liability undiscounted excess amount changed year-over-year?
- Krystal Biotech, Inc.'s lessee operating lease liability undiscounted excess amount decreased by 11.6% year-over-year, from $8.44M to $7.46M.